Quest Diagnostics Incorporated (DGX)
$207.87+0.79%
Spriggl Score: Good— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“Dominant US testing network, reliable cash compounder; reimbursement headwinds cap the upside.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic informatio…
- Sector:
- Healthcare
- Industry:
- Diagnostics & Research
- Market Cap:
- $21.6B
Recent dividends
- 8 Jul 2026$0.86
- 6 Apr 2026$0.86
- 13 Jan 2026$0.80
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Quest Diagnostics Incorporated and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free